Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, dated August 19, 2025, reports a transaction in own shares. Haleon is a global leader in consumer health with a portfolio spanning oral health, vitamins, pain relief, respiratory health, digestive health, and therapeutic skin health.
Key Financial Metrics
The filing details a share buyback transaction rather than operational financial results. Key metrics from the transaction include:
- Shares Purchased: 1,504,400 ordinary shares for cancellation.
- Transaction Date: August 18, 2025.
- Price Range: Highest price paid was 359.80 pence; lowest was 356.10 pence.
- Volume Weighted Average Price: 358.0459 pence per share.
- Post-Transaction Capital: Registered share capital stands at 8,971,802,095 ordinary shares of £0.01 each.
- Treasury Shares: 3,880,205 shares held as treasury shares.
- Voting Rights: 8,967,921,890 ordinary shares with voting rights.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity for the period.
Material Changes
This transaction represents the second tranche of a share buyback programme announced on July 31, 2025. The purchase reduces the number of shares outstanding and increases the proportion of voting rights held by remaining shareholders.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, or specific risks. It notes that the announcement does not constitute an offer or solicitation of an offer for securities. A full breakdown of individual trades is available via the London Stock Exchange link provided in the document.
Investor Verification Checklist
- Verify the total number of shares purchased under the full buyback programme announced on July 31, 2025.
- Confirm the remaining authorization limit for the share buyback programme.
- Review the full trade breakdown at the provided London Stock Exchange link for intraday pricing details.
- Check subsequent filings for the impact of this buyback on earnings per share (EPS) and capital structure.